MULTI-INSTITUTIONAL VALIDATION OF A SYMPTOM BASED CLASSIFICATION FOR RENAL CELL CARCINOMA
- 1 September 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 172 (3), 858-862
- https://doi.org/10.1097/01.ju.0000135837.64840.55
Abstract
We validate the prognostic value of a symptom based classification (S classification) in a multi-institutional study.A total of 2,242 patients from 5 European centers were included in this study. Based on symptoms at diagnosis, patients were stratified into 3 groups of S1-asymptomatic tumors, S2-tumors with local symptoms and S3-tumors with systemic symptoms. Variables such as age, gender, tumor size, TNM stage, Fuhrman grade, Eastern Cooperative Oncology Group (ECOG) performance status, perinephric fat, renal vein and adrenal invasion were also considered for prognostic value. The end point of the study was cancer specific survival. Survival assessment was made with univariate and multivariate analyses using the Kaplan-Meier method and Cox regression analysis.Of the patients 1,018 (45.4%) were classified as S1, 865 (38.6%) S2 and 339 (16.0%) S3. The S classification correlated to tumor stage, grade and ECOG (p <0.001). On univariate analysis ECOG performance status, S classification, tumor size, TNM stage, Fuhrman grade, and adrenal, perinephric fat or vein invasion were significant prognostic factors (p <0.001). The S classification provided a significant prognostic stratification in the aggregate as well at each of the 5 centers. On multivariate analysis the S classification, TNM stage, Fuhrman grade, and perinephric fat and renal vein invasion remained independent prognostic factors (p <0.001).This study confirms that it is possible to graduate symptoms for a prognostic purpose. The proposed symptom score should be evaluated for its integration in prognostic algorithms.Keywords
This publication has 18 references indexed in Scilit:
- Correlation between Symptom Graduation, Tumor Characteristics and Survival in Renal Cell CarcinomaEuropean Urology, 2003
- Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell CarcinomaJournal of Clinical Oncology, 2002
- An Outcome Prediction Model for Patients with Clear Cell Renal Cell Carcinoma Treated with Radical Nephrectomy Based on Tumor Stage, Size, Grade and Necrosis: The Ssign ScoreJournal of Urology, 2002
- The differences in health outcomes between Web‐based and paper‐based implementation of a clinical pathway for radical nephrectomyBJU International, 2002
- Prognostic significance of the mode of detection in renal tumoursBJU International, 2002
- Prognostic assessment of nonmetastatic renal cell carcinoma: a clinically based modelUrology, 2001
- A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMAJournal of Urology, 2001
- PROGNOSTIC INDICATORS FOR RENAL CELL CARCINOMA: A MULTIVARIATE ANALYSIS OF 643 PATIENTS USING THE REVISED 1997 TNM STAGING CRITERIAJournal of Urology, 2000
- TNM staging of renal cell carcinomaCancer, 1997
- Prognostic Significance of Incidental Renal Cell CarcinomaEuropean Urology, 1995